BRAZILIAN CONSENSUS STATEMENT ON VISCOSUPPLEMENTATION OF THE HIP (COBRAVI-Q).

Autor:	Sousa EB; Instituto Nacional de Traumatologia e Ortopedia, Rio de Janeiro, RJ, Brazil., Hamdan PC; Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Menegassi ZJB; Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Alchaar AADA; Hospital Municipal Miguel Couto, Rio de Janeiro, RJ, Brazil., Tieppo AM; Santa Casa de Misericórdia de São Paulo, School of Medicine, São Paulo, SP, Brazil., Souza CG; Universidade de São Paulo, School of Medicine, Department of Orthopedics and Traumatology, São Paulo, SP, Brazil., Pinheiro CBR; Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Almeida CS; Santa Casa de Misericórdia de São Paulo, School of Medicine, São Paulo, SP, Brazil., Rocha EMC; Santa Casa de Misericórdia de São Paulo, School of Medicine, São Paulo, SP, Brazil., Cunha FG; Hospital Santa Paula, São Paulo, SP, Brazil., Pacheco I; Hospital Moinhos de Vento, Porto Alegre, RS, Brazil., Rezende MU; Universidade de São Paulo, School of Medicine, Department of Orthopedics and Traumatology, São Paulo, SP, Brazil., Souza MPG; Universidade de São Paulo, School of Medicine, Department of Orthopedics and Traumatology, São Paulo, SP, Brazil., Britto DA Silva M; Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Campos GC; Universidade Estadual de Campinas, School of Medical Sciences, Department of Orthopedics and Traumatology, Campinas, SP, Brazil.
Jazyk:	angličtina
Zdroj:	Acta ortopedica brasileira [Acta Ortop Bras] 2022 Nov 11; Vol. 30 (5), pp. e250414. Date of Electronic Publication: 2022 Nov 11 (Print Publication: 2022).
DOI:	10.1590/1413-785220223005e250414
Abstrakt:	Objective: The Brazilian Consensus on Hip Viscosupplementation aims to generate a referential and consensual source from the theoretical knowledge and clinical experience of specialists in the field. Methods: A multidisciplinary panel was formed with 15 specialists (sports medicine, orthopedists, physiatrists and rheumatologists), based on clinical and academic experience in the use of viscosupplementation of the hip. 12 statements were prepared, discussed and voted. Each panelist gave a value between 0 and 10 on a Likert scale, specifying their level of agreement with the statement. Results: The panel reached a consensus on several aspects of viscosupplementation of the hip, with emphasis on the following statements: best indication is for mild to moderate hip arthrosis; it may be indicated in severe osteoarthritis; results may vary according to the characteristics of the viscosupplement used; Viscosupplementation should not be performed as an isolated procedure, but in conjunction with other rehabilitation and pharmacological measures; best injection technique should be based on anatomical references coupled with imaging guidance; it is a cost-effective procedure. Conclusion: Viscosupplementation is a safe and effective therapy for hip osteoarthritis, even in severe cases. Guided injection is recommended. Level of Evidence V, Expert Opinion. Competing Interests: All authors declare no potential conflict of interest related to this article.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu